APOTEX INC.

In News

Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses - PR Newswire

PR Newswire - Apr 23, 2026

Shed Pounds, Save Big Bucks: FDA Clears Way for First Low-Price Generic Drug for Weight Loss - inc.com

inc.com - Apr 13, 2026

Apotex announces leadership changes - PR Newswire

PR Newswire - Mar 30, 2026

Apotex plans $1-billion initial public offering - The Globe and Mail

The Globe and Mail - Feb 24, 2026

DifGen Pharmaceuticals LLC, in Collaboration with Apotex Inc., Announces FDA Approval of Generic Nintedanib Soft Gel Capsules, 100 mg and 150mg Therapeutically Equivalent to Ofev® - Yahoo Finance

Yahoo Finance - Apr 09, 2026

Canada’s IPO market looks for revival with AGT, Apotex deals - MSN

MSN - Feb 25, 2026

Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions - The Globe and Mail

The Globe and Mail - Apr 12, 2026

Apotex Strengthens Osteoporosis Care in Canada with Health Canada's Approval of DENOZA™, a Denosumab Biosimilar - PR Newswire

PR Newswire - Apr 07, 2026

Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer - PR Newswire

PR Newswire - Oct 23, 2025

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment - PR Newswire

PR Newswire - Oct 07, 2025

Apotex Expands Canadian Ophthalmology Portfolio with Health Canada's Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%) - PR Newswire

PR Newswire - Mar 25, 2026

Apotex Announces FDA Approval of First Generic Infuvite® Adult Injection (Single Dose Vial and Pharmacy Bulk package) with 180‑Day CGT Exclusivity for the Pharmacy bulk package in Partnership with Orbicular and Gland Pharma - PR Newswire

PR Newswire - Apr 14, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment